SCHEMBL29699513

SCHEMBL29699513

Cc1ccnc(S(C)(=O)=O)c1NC(=O)c1ncccc1C(N)=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.44
P2RX7 Q99572 1/20 0.40
RAB9A P51151 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
NPC1 O15118 2/20 0.38
MAPT P10636 2/20 0.38
AHR P35869 1/20 0.38
ALDH1A1 P00352 5/20 0.37
HPGD P15428 2/20 0.37
HSD17B10 Q99714 1/20 0.36
KMT2A Q03164 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
ATR Q13535 1/20 0.36
PABPC1 P11940 1/20 0.35
EIF4H Q15056 1/20 0.35
PARP1 P09874 1/20 0.35
SYK P43405 1/20 0.34
SIRT3 Q9NTG7 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
POLB P06746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25225128 0.80 KDM4E (0.45) KDM4EP2RX7RAB9ASMN1; SMN2NPC1
SCHEMBL9953506 0.75 PARP1 (0.50) KDM4EP2RX7RAB9ASMN1; SMN2NPC1
SCHEMBL29699541 0.75 PABPC1 (0.56) KDM4ESMN1; SMN2MAPTALDH1A1KMT2A
SCHEMBL7452418 0.71 KDM4E (0.49) KDM4EP2RX7RAB9ASMN1; SMN2NPC1
SCHEMBL28276095 0.70 PRKCI (0.63) KDM4EMAPTALDH1A1HPGDHSD17B10
SCHEMBL5902495 0.69 PARP1 (0.50) KDM4EP2RX7RAB9ASMN1; SMN2NPC1
SCHEMBL29082826 0.69 P2RX7 (0.62) KDM4EP2RX7RAB9ASMN1; SMN2NPC1
SCHEMBL28151967 0.68 POLB (0.50) KDM4ERAB9ANPC1MAPTALDH1A1
SCHEMBL7451831 0.67 KDM4E (0.46) KDM4EP2RX7RAB9ASMN1; SMN2NPC1
SCHEMBL7452205 0.67 KDM4E (0.52) KDM4EP2RX7RAB9ASMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115175908-B Aryl or heteroaryl pyridone or pyrimidinone derivatives, and preparation method and application thereof 苏州泽璟生物制药股份有限公司 2024-07-23 CN disclosed
US-20230118795-A1 ARYL OR HETEROARYL PYRIDONE OR PYRIMIDINE DERIVATIVE, PREPARATION METHOD AND USE THEREOF SUZHOU ZELGEN BIOPHARMACEUTICALS CO., LTD. (CN) 2023-04-20 US disclosed
EP-4092026-A1 ARYL OR HETEROARYL PYRIDONE OR PYRIMIDINE DERIVATIVE, PREPARATION METHOD AND USE THEREOF Suzhou Zelgen Biopharmaceutical Co., Ltd. (CN) 2022-11-23 EP disclosed
CN-115175908-A Aryl or heteroaryl pyridone or pyrimidone derivative and preparation method and application thereof 苏州泽璟生物制药股份有限公司 2022-10-11 CN disclosed
WO-2022135591-A1 ARYL OR HETEROARYL PYRIDONE OR PYRIMIDONE DERIVATIVE AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 苏州泽璟生物制药股份有限公司 2022-06-30 WO disclosed
CN-114671866-A Aryl or heteroaryl pyridone or pyrimidone derivative and preparation method and application thereof 苏州泽璟生物制药股份有限公司 2022-06-28 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230118795-A1 ARYL OR HETEROARYL PYRIDONE OR PYRIMIDINE DERIVATIVE, PREPARATION METHOD AND USE THEREOF KRAS, NRAS, HRAS KDM4E 2612/4885P2RX7 964/4885RAB9A 151/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.